These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30015640)

  • 61. Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China.
    Li J; Zheng K; Deng Z; Zheng J; Ma H; Sun L; Chen W
    Eye Contact Lens; 2015 Jan; 41(1):44-50. PubMed ID: 25232992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dry Eye Disease: Present Challenges in the Management and Future Trends.
    Al-Saedi Z; Zimmerman A; Bachu RD; Dey S; Shah Z; Baugh R; Boddu SH
    Curr Pharm Des; 2016; 22(28):4470-90. PubMed ID: 27296759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging therapeutics for ocular surface disease.
    Bielory BP; Shah SP; O'Brien TP; Perez VL; Bielory L
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):477-86. PubMed ID: 27585059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye.
    Gaffney EA; Tiffany JM; Yokoi N; Bron AJ
    Prog Retin Eye Res; 2010 Jan; 29(1):59-78. PubMed ID: 19944776
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antigen-presenting cells in ocular surface diseases.
    Kalogeropoulos D; Papoudou-Bai A; Lane M; Goussia A; Charchanti A; Moschos MM; Kanavaros P; Kalogeropoulos C
    Int Ophthalmol; 2020 Jun; 40(6):1603-1618. PubMed ID: 32107692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammation in Dry Eye Disease-Pathogenesis, Preclinical Animal Models, and Treatments.
    Bhujbal S; Rupenthal ID; Steven P; Agarwal P
    J Ocul Pharmacol Ther; 2024 Dec; 40(10):638-658. PubMed ID: 39358844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry.
    Pieragostino D; Agnifili L; Cicalini I; Calienno R; Zucchelli M; Mastropasqua L; Sacchetta P; Del Boccio P; Rossi C
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dynamic change of optical quality in patients with dry eye disease.
    Tan CH; Labbé A; Liang Q; Qiao L; Baudouin C; Wan X; Wang N
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):2848-54. PubMed ID: 25650418
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role and treatment of inflammation in dry eye disease.
    Yagci A; Gurdal C
    Int Ophthalmol; 2014 Dec; 34(6):1291-301. PubMed ID: 25416345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
    Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
    Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ocular allergy.
    Friedlaender MH
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):477-82. PubMed ID: 21822130
    [TBL] [Abstract][Full Text] [Related]  

  • 74. α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways.
    Ru Y; Huang Y; Liu H; Du J; Meng Z; Dou Z; Liu X; Wei RH; Zhang Y; Zhao S
    Sci Rep; 2015 Dec; 5():18619. PubMed ID: 26685899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease].
    Knop E; Knop N; Brewitt H
    Ophthalmologe; 2003 Nov; 100(11):917-28. PubMed ID: 14669027
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Advances in the diagnosis and therapy for diseases of the ocular surface: dry eye and ocular allergies].
    Messmer EM; Benitez del Castello J; Lambiase A; Doan S
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):643-9. PubMed ID: 16927218
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dry Eye Disease: Consideration for Women's Health.
    Matossian C; McDonald M; Donaldson KE; Nichols KK; MacIver S; Gupta PK
    J Womens Health (Larchmt); 2019 Apr; 28(4):502-514. PubMed ID: 30694724
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy.
    Ji H; Zhu Y; Zhang Y; Li Z; Ge J; Zhuo Y
    PLoS One; 2016; 11(3):e0152696. PubMed ID: 27032098
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
    Na KS; Mok JW; Kim JY; Rho CR; Joo CK
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigational drugs in dry eye disease.
    Nebbioso M; Fameli V; Gharbiya M; Sacchetti M; Zicari AM; Lambiase A
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1437-1446. PubMed ID: 27754718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.